Robert Wesolowski

Robert Wesolowski, MD


Make an Appointment

Overall Patient Satisfaction Rating

4.8 out of 5






I am a medical oncologist who specializes in treating patients diagnosed with breast cancer.

My clinical specialties include female and male breast cancers, breast cancer immunology, ductal breast carcinomas, lobular carcinomas, medullary carcinomas, hereditary breast and ovarian cancer syndrome, and inflammatory breast cancers.

My research focuses on breast cancer immunology. I study the interaction of the immune system with cancer with the goal of improving and expanding the use of immunotherapies to shrink tumors. In the laboratory, we are researching ways to inhibit or destroy myeloid-derived suppressor cells in hopes of boosting antitumor immune response in patients with cancer. We are also testing combinations of therapies that could inhibit myeloid-derived suppressor cells and increase the killing ability of T cells. Our goal is to develop the best therapies that can be tested in patients with breast and other cancers.

In addition to treating patients and conducting laboratory research. I am a principal investigator on several phase I trials that test promising therapies in patients with breast cancer and other solid tumors.

In 2013, 2015, 2016 and 2017, I was recognized as a high-performing physician at The Ohio State University Wexner Medical Center based on patient-satisfaction scores and I was also listed among the top 10 percent of physicians who achieved highest patient satisfaction on a national level in 2013 and 2015. In 2013 I received the Physician "Champion of Nursing" Excellence Award from the OSUCCC – James. I am honored to be a Courage, Conquer & Cure Foundation Award recipient for showing dedication to breast cancer research and outstanding patient care. In addition, I was recognized as central Ohio’s best doctors of 2015-2016 and 2017-2018 in medical oncology and hematology, a listing that appeared in Columbus Business First in October 2015 and 2017.

Education and Background


SUNY Downstate Medical College

Brooklyn, NY


Cleveland Clinic Foundation

Cleveland, OH



Cleveland Clinic Foundation

Cleveland, OH

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine (Subspecialty: Medicine Oncology)

Academic Department

Department of Internal Medicine

Division of Medical Oncology

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 11/21/2019, Dr. Wesolowski has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.


Pfizer, Inc.

Roche Diagnostics

Puma Biotechnology


Patient Satisfaction Review

The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.

Overall Ratings (out of 66 reviews)
4.8 out of 5
Kept you informed about your condition and treatment

4.8/ 5

Amount of time spent with you

4.8/ 5

Concern for your questions and issues

4.8/ 5

Skill and knowledge

4.9/ 5

Overall quality of care

4.9/ 5

Patient Comments (3 total comments)

Reviewed: 8/22/2019

I was seen by 2 doctors at my last appt. I was very pleased with both of them & their concerns! I have never met a more caring team if doctors, anywhere!

Reviewed: 6/26/2019


Reviewed: 4/23/2019

5. Dr. Wesolowski is wonderful.


A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody-drug conjugate, in patients with breast cancer and other advanced solid tumors.

Rosen LS, Wesolowski R, Baffa R, Liao KH, Hua SY, Gibson BL, Pirie-Shepherd S, Tolcher AW

Invest New Drugs in press


Physical Activity After Breast Cancer Surgery: Does Depression Make Exercise Feel More Effortful than It Actually Is?

Padin AC, Wilson SJ, Bailey BE, Malarkey WB, Lustberg MB, Farrar WB, Povoski SP, Agnese DM, Reinbolt RE, Wesolowski R, Williams N, Sardesai S, Ramaswamy B, Noonan AM, Vandeusen JB, Haas GJ, Kiecolt-Glaser JK

Int J Behav Med in press


Clinical Trials | Lead




Back to Find a Doctor Search

Make an Appointment


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Please enter a keyword (i.e. Name, Location) or choose a Cancer Type